These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23716043)

  • 1. Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients.
    Kawai Y; Miyashita N; Kubo M; Akaike H; Kato A; Nishizawa Y; Saito A; Kondo E; Teranishi H; Wakabayashi T; Ogita S; Tanaka T; Kawasaki K; Nakano T; Terada K; Ouchi K
    Antimicrob Agents Chemother; 2013 Aug; 57(8):4046-9. PubMed ID: 23716043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan.
    Matsuda K; Narita M; Sera N; Maeda E; Yoshitomi H; Ohya H; Araki Y; Kakuma T; Fukuoh A; Matsumoto K
    BMC Infect Dis; 2013 Dec; 13():591. PubMed ID: 24330612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008-2015.
    Tanaka T; Oishi T; Miyata I; Wakabayashi S; Kono M; Ono S; Kato A; Fukuda Y; Saito A; Kondo E; Teranishi H; Tanaka Y; Wakabayashi T; Akaike H; Ogita S; Ohno N; Nakano T; Terada K; Ouchi K
    Emerg Infect Dis; 2017 Oct; 23(10):1703-1706. PubMed ID: 28930026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional Differences in Prevalence of Macrolide Resistance among Pediatric Mycoplasma pneumoniae Infections in Hokkaido, Japan.
    Ishiguro N; Koseki N; Kaiho M; Kikuta H; Togashi T; Oba K; Morita K; Nagano N; Nakanishi M; Hazama K; Watanabe T; Sasaki S; Horino A; Kenri T; Ariga T;
    Jpn J Infect Dis; 2016 May; 69(3):186-90. PubMed ID: 26166502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].
    Yin YD; Cao B; Wang H; Wang RT; Liu YM; Gao Y; Qu JX; Han GJ; Liu YN
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):954-8. PubMed ID: 24503430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia.
    Miyashita N; Oka M; ; Kawai Y; Yamaguchi T; Ouchi K
    Int J Antimicrob Agents; 2010 Oct; 36(4):384-5. PubMed ID: 20674283
    [No Abstract]   [Full Text] [Related]  

  • 7. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.
    Miyashita N; Kawai Y; Akaike H; Ouchi K; Hayashi T; Kurihara T; Okimoto N;
    BMC Infect Dis; 2012 May; 12():126. PubMed ID: 22650321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First Detection and Characterization of Macrolide-Resistant
    Noori Goodarzi N; Pourmand MR; Arfaatabar M; Azimi G; Masoorian E; Rahimi Foroushani A; Aminharati F; Heidarzadeh S; Baghani A
    Microb Drug Resist; 2020 Mar; 26(3):245-250. PubMed ID: 31545147
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.
    Li X; Atkinson TP; Hagood J; Makris C; Duffy LB; Waites KB
    Pediatr Infect Dis J; 2009 Aug; 28(8):693-6. PubMed ID: 19633515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilocus Sequence Typing of Mycoplasma pneumoniae, Japan, 2002-2016.
    Ando M; Morozumi M; Adachi Y; Ubukata K; Iwata S
    Emerg Infect Dis; 2018 Oct; 24(10):1895-1901. PubMed ID: 30226158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.
    Liu Y; Ye X; Zhang H; Xu X; Li W; Zhu D; Wang M
    Antimicrob Agents Chemother; 2009 May; 53(5):2160-2. PubMed ID: 19273684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of 11 antimicrobial agents against macrolide-resistant Mycoplasma pneumoniae isolates from pediatric patients: results from a multicenter surveillance study.
    Akaike H; Miyashita N; Kubo M; Kawai Y; Tanaka T; Ogita S; Kawasaki K; Nakano T; Terada K; Ouchi K;
    Jpn J Infect Dis; 2012; 65(6):535-8. PubMed ID: 23183207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China.
    Xin D; Mi Z; Han X; Qin L; Li J; Wei T; Chen X; Ma S; Hou A; Li G; Shi D
    Antimicrob Agents Chemother; 2009 May; 53(5):2158-9. PubMed ID: 19273685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients.
    Matsubara K; Morozumi M; Okada T; Matsushima T; Komiyama O; Shoji M; Ebihara T; Ubukata K; Sato Y; Akita H; Sunakawa K; Iwata S
    J Infect Chemother; 2009 Dec; 15(6):380-3. PubMed ID: 20012728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycoplasma pneumoniae among Chinese Outpatient Children with Mild Respiratory Tract Infections during the Coronavirus Disease 2019 Pandemic.
    Chen J; Zhang J; Lu Z; Chen Y; Huang S; Li H; Lin S; Yu J; Zeng X; Ji C; Zheng Y; Dai F; Dong W; Xu H; Chen W; Jin X; Cui Z; Qiao J; Qin W; Chen H; Jiang W; Zhang X; Song J; Shao J; Su W; Wang C; Liu F; Zhao Y; Zou Y; Guo R; Zhang L; Wu J; Yuan S; Tang M; Wu Y; Lin J; Dong W; Chen X; Sun X; Yin Y
    Microbiol Spectr; 2022 Feb; 10(1):e0155021. PubMed ID: 35138173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.
    Matsuoka M; Narita M; Okazaki N; Ohya H; Yamazaki T; Ouchi K; Suzuki I; Andoh T; Kenri T; Sasaki Y; Horino A; Shintani M; Arakawa Y; Sasaki T
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4624-30. PubMed ID: 15561835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014.
    Kogoj R; Mrvic T; Praprotnik M; Kese D
    Euro Surveill; 2015; 20(37):. PubMed ID: 26536357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Efficacy of Antimicrobial Agents Among Hospitalized Patients With Mycoplasma pneumoniae Pneumonia in Japan During Large Epidemics of Macrolide-Resistant M. pneumoniae Infections: A Nationwide Observational Study.
    Tashiro M; Fushimi K; Kawano K; Takazono T; Saijo T; Yamamoto K; Kurihara S; Imamura Y; Miyazaki T; Yanagihara K; Mukae H; Izumikawa K
    Clin Infect Dis; 2017 Nov; 65(11):1837-1842. PubMed ID: 29020161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009.
    Suzuki Y; Itagaki T; Seto J; Kaneko A; Abiko C; Mizuta K; Matsuzaki Y
    Pediatr Infect Dis J; 2013 Mar; 32(3):237-40. PubMed ID: 23114374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolide-Resistant Mycoplasma pneumoniae in the United States as Determined from a National Surveillance Program.
    Waites KB; Ratliff A; Crabb DM; Xiao L; Qin X; Selvarangan R; Tang YW; Zheng X; Dien Bard J; Hong T; Prichard M; Brooks E; Dallas S; Duffy L; Mixon E; Fowler KB; Atkinson TP
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31484701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.